Addition: The author list has been updated to include Jean-François Brazeau, Bristol Myers Squibb, San Diego, California 92121, United States. Addition: Specific references to patent litearture disclosures have been added (refs (2−11) here), where we had previously referenced only a review article of the patent literature. We have also added one reference from the scientific literature found during this reference update (ref (1) here), though this paper was likely under review at the time of our manuscript submission. p16388: While there have been several recent disclosures of similar nontraditional CRBN binders in the scientific (1) and patent (2−11) literature, these had not been disclosed at the time of the work described here. This article references 11 other publications. This article has not yet been cited by other publications.

中文翻译：

---

对“用于靶向蛋白质降解的新型 Cereblon 结合剂的设计和合成”的更正


添加：作者列表已更新，包括 Jean-François Brazeau， Bristol Myers Squibb，San Diego，California 92121，United States。添加：添加了对专利文献披露的具体参考（此处参考文献（2−11）），我们之前仅参考了专利文献的评论文章。我们还添加了在此参考更新期间找到的科学文献中的一篇参考文献（此处参考文献 (1)），尽管这篇论文在我们提交手稿时可能正在接受审查。 p16388：虽然最近在科学 (1) 和专利 (2−11) 文献中披露了一些类似的非传统 CRBN 粘合剂，但在本文描述的工作时尚未披露这些内容。本文引用了其他 11 篇出版物。这篇文章尚未被其他出版物引用。